Bellicum Pharmaceuticals Ownership 2024 | Who Owns Bellicum Pharmaceuticals Now?

Overview RevenueFinancials Chart

Institutional Ownership

1.52%

Insider Ownership

0.99%

Retail Ownership

97.50%

Institutional Holders

4.00

Bellicum Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
IKARIAN CAPITAL, LLC	1.45%	0.03%	448,101	-	-	147,873,000	Mar 31, 2023
LONG FOCUS CAPITAL MANAGEMENT, LLC	1.06%	0.01%	327,692	-	-	108,138,000	Mar 31, 2023
BAKER BROS. ADVISORS LP	0.81%	0.00%	249,123	-	-	82,211,000	Mar 31, 2023
BLACKROCK INC.	0.25%	-	75,753	-145	-0.19%	24,999,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.24%	-	72,770	-	-	24,014,000	Mar 31, 2023
VANGUARD GROUP INC	0.22%	-	66,309	-115,534	-63.53%	21,882,000	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	0.15%	0.00%	45,057	-	-	14,869,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.10%	-	30,177	-12,133	-28.68%	9,958,000	Mar 31, 2023
STATE STREET CORP	0.09%	-	27,245	-	-	8,991,000	Mar 31, 2023
JANE STREET GROUP, LLC	0.07%	-	20,077	3,755	23.01%	6,625,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.05%	-	14,000	300	2.19%	5,000	Mar 31, 2023
MORGAN STANLEY	0.05%	-	13,962	279	2.04%	4,607,000	Mar 31, 2023
NORTHERN TRUST CORP	0.04%	-	10,981	-	-	3,624,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.03%	0.00%	7,844	-3,676	-31.91%	3,000	Mar 31, 2023
TEKLA CAPITAL MANAGEMENT LLC	0.02%	0.00%	6,000	-	-	1,980,000	Mar 31, 2023
UBS GROUP AG	0.01%	-	3,057	-453	-12.91%	1,009,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	2,998	988	49.15%	975,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	1,066	-	-	352,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	782	1	0.13%	258,000	Mar 31, 2023
PRINCETON GLOBAL ASSET MANAGEMENT LLC	0.00%	-	100	100	100.00%	33,000	Mar 31, 2023

Bellicum Pharmaceuticals's largest institutional shareholder is IKARIAN CAPITAL, LLC, holding 1.45% of the company's total share outstanding, currently valued at $147.87M. The top 10 institutional shareholders own together 4.42% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
IKARIAN CAPITAL, LLC	1.45%	0.03%	448,101	-	-	147,873,000	Mar 31, 2023
LONG FOCUS CAPITAL MANAGEMENT, LLC	1.06%	0.01%	327,692	-	-	108,138,000	Mar 31, 2023
BAKER BROS. ADVISORS LP	0.81%	0.00%	249,123	-	-	82,211,000	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	0.15%	0.00%	45,057	-	-	14,869,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.03%	0.00%	7,844	-3,676	-31.91%	3,000	Mar 31, 2023
TEKLA CAPITAL MANAGEMENT LLC	0.02%	0.00%	6,000	-	-	1,980,000	Mar 31, 2023
PRINCETON GLOBAL ASSET MANAGEMENT LLC	0.00%	-	100	100	100.00%	33,000	Mar 31, 2023
TRUVESTMENTS CAPITAL LLC	0.00%	-	41	-	-	14,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.05%	-	14,000	300	2.19%	5,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.24%	-	72,770	-	-	24,014,000	Mar 31, 2023
JANE STREET GROUP, LLC	0.07%	-	20,077	3,755	23.01%	6,625,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.10%	-	30,177	-12,133	-28.68%	9,958,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	2,998	988	49.15%	975,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	1,066	-	-	352,000	Mar 31, 2023
BLACKROCK INC.	0.25%	-	75,753	-145	-0.19%	24,999,000	Mar 31, 2023
NORTHERN TRUST CORP	0.04%	-	10,981	-	-	3,624,000	Mar 31, 2023
VANGUARD GROUP INC	0.22%	-	66,309	-115,534	-63.53%	21,882,000	Mar 31, 2023
STATE STREET CORP	0.09%	-	27,245	-	-	8,991,000	Mar 31, 2023
MORGAN STANLEY	0.05%	-	13,962	279	2.04%	4,607,000	Mar 31, 2023
UBS GROUP AG	0.01%	-	3,057	-453	-12.91%	1,009,000	Mar 31, 2023

The largest Bellicum Pharmaceuticals shareholder by % of total assets is IKARIAN CAPITAL, LLC. The company owns 448.10K shares of Bellicum Pharmaceuticals (BLCM), representing 0.03% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JANE STREET GROUP, LLC	0.07%	-	20,077	3,755	23.01%	6,625,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	2,998	988	49.15%	975,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.05%	-	14,000	300	2.19%	5,000	Mar 31, 2023
MORGAN STANLEY	0.05%	-	13,962	279	2.04%	4,607,000	Mar 31, 2023
PRINCETON GLOBAL ASSET MANAGEMENT LLC	0.00%	-	100	100	100.00%	33,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	782	1	0.13%	258,000	Mar 31, 2023
PARALLEL ADVISORS, LLC	-	-	10	-	-	3,000	Mar 31, 2023
STATE STREET CORP	0.09%	-	27,245	-	-	8,991,000	Mar 31, 2023
NORTHERN TRUST CORP	0.04%	-	10,981	-	-	3,624,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	1,066	-	-	352,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.24%	-	72,770	-	-	24,014,000	Mar 31, 2023
TRUVESTMENTS CAPITAL LLC	0.00%	-	41	-	-	14,000	Mar 31, 2023
TEKLA CAPITAL MANAGEMENT LLC	0.02%	0.00%	6,000	-	-	1,980,000	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	0.15%	0.00%	45,057	-	-	14,869,000	Mar 31, 2023
BAKER BROS. ADVISORS LP	0.81%	0.00%	249,123	-	-	82,211,000	Mar 31, 2023
LONG FOCUS CAPITAL MANAGEMENT, LLC	1.06%	0.01%	327,692	-	-	108,138,000	Mar 31, 2023
IKARIAN CAPITAL, LLC	1.45%	0.03%	448,101	-	-	147,873,000	Mar 31, 2023
NORTH STAR INVESTMENT MANAGEMENT CORP.	-	-	-	-1	-100.00%	-	Mar 31, 2023
BLACKROCK INC.	0.25%	-	75,753	-145	-0.19%	24,999,000	Mar 31, 2023
MONEY CONCEPTS CAPITAL CORP	-	-	-	-264	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Bellicum Pharmaceuticals's largest institutional buyer is JANE STREET GROUP, LLC. The company purchased 3.75K stocks of BLCM, valued at $6.63M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	0.22%	-	66,309	-115,534	-63.53%	21,882,000	Mar 31, 2023
BOXER CAPITAL, LLC	-	-	-	-56,950	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-36,470	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-21,595	-100.00%	-	Mar 31, 2023
ERGOTELES LLC	-	-	-	-18,105	-100.00%	-	Mar 31, 2023
SHUFRO ROSE & CO LLC	-	-	-	-12,941	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.10%	-	30,177	-12,133	-28.68%	9,958,000	Mar 31, 2023
LPL FINANCIAL LLC	-	-	-	-10,527	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.03%	0.00%	7,844	-3,676	-31.91%	3,000	Mar 31, 2023
ORION CAPITAL MANAGEMENT LLC	-	-	-	-500	-100.00%	-	Mar 31, 2023
UBS GROUP AG	0.01%	-	3,057	-453	-12.91%	1,009,000	Mar 31, 2023
MONEY CONCEPTS CAPITAL CORP	-	-	-	-264	-100.00%	-	Mar 31, 2023
BLACKROCK INC.	0.25%	-	75,753	-145	-0.19%	24,999,000	Mar 31, 2023
NORTH STAR INVESTMENT MANAGEMENT CORP.	-	-	-	-1	-100.00%	-	Mar 31, 2023
IKARIAN CAPITAL, LLC	1.45%	0.03%	448,101	-	-	147,873,000	Mar 31, 2023
LONG FOCUS CAPITAL MANAGEMENT, LLC	1.06%	0.01%	327,692	-	-	108,138,000	Mar 31, 2023
BAKER BROS. ADVISORS LP	0.81%	0.00%	249,123	-	-	82,211,000	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	0.15%	0.00%	45,057	-	-	14,869,000	Mar 31, 2023
TEKLA CAPITAL MANAGEMENT LLC	0.02%	0.00%	6,000	-	-	1,980,000	Mar 31, 2023
TRUVESTMENTS CAPITAL LLC	0.00%	-	41	-	-	14,000	Mar 31, 2023

As of Mar 31 2023, Bellicum Pharmaceuticals's biggest institutional seller is VANGUARD GROUP INC. The company sold -0.12M shares of BLCM, valued at $21.88M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PRINCETON GLOBAL ASSET MANAGEMENT LLC	0.00%	-	100	100	100.00%	33,000	Mar 31, 2023

Bellicum Pharmaceuticals's largest new institutional shareholder by number of shares is PRINCETON GLOBAL ASSET MANAGEMENT LLC, purchased 100.00 shares, valued at $33.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BOXER CAPITAL, LLC	-	-	-	-56,950	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-36,470	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-21,595	-100.00%	-	Mar 31, 2023
ERGOTELES LLC	-	-	-	-18,105	-100.00%	-	Mar 31, 2023
SHUFRO ROSE & CO LLC	-	-	-	-12,941	-100.00%	-	Mar 31, 2023
LPL FINANCIAL LLC	-	-	-	-10,527	-100.00%	-	Mar 31, 2023
ORION CAPITAL MANAGEMENT LLC	-	-	-	-500	-100.00%	-	Mar 31, 2023
MONEY CONCEPTS CAPITAL CORP	-	-	-	-264	-100.00%	-	Mar 31, 2023
NORTH STAR INVESTMENT MANAGEMENT CORP.	-	-	-	-1	-100.00%	-	Mar 31, 2023

Bellicum Pharmaceuticals's largest sold out institutional shareholder by shares sold is BOXER CAPITAL, LLC, sold -56.95K shares, valued at -, as of undefined.

Bellicum Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
BRIDGEWAY FUNDS INC	0.03%	71,700	-	-	Dec 29, 2023
TEKLA LIFE SCIENCES INVESTORS	0.01%	6,000	-	-	Dec 31, 2023
BRIDGEWAY FUNDS INC	0.01%	25,000	-	-	Dec 29, 2023
FIDELITY COMMONWEALTH TRUST	0.00%	6,013	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	70,672	-	-	Feb 29, 2024
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	0.00%	10,400	-	-	Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	4,992	-	-	Dec 31, 2023
VANGUARD INDEX FUNDS	0.00%	59,361	-	-	Dec 31, 2023
VANGUARD QUANTITATIVE FUNDS	0.00%	175	-	-	Dec 31, 2023
VALIC Co I	0.00%	3,900	-	-	Feb 29, 2024
Ark ETF Trust	0.00%	56	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	1,280	-	-	Dec 31, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	1,059	-	-	Dec 31, 2023
iSHARES TRUST	0.00%	6,785	-	-	Feb 29, 2024

Bellicum Pharmaceuticals's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 71.70K shares, compromising 0.03% of its total assets.

Bellicum Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 23	4	-80.95%
31 Mar, 23	21	-27.59%
31 Dec, 22	29	38.10%
30 Sep, 22	21	-4.55%
30 Jun, 22	22	-
31 Mar, 22	22	22.22%
31 Dec, 21	18	-18.18%
30 Sep, 21	22	-8.33%
30 Jun, 21	24	9.09%
31 Mar, 21	22	-18.52%
31 Dec, 20	27	50.00%
30 Sep, 20	18	-30.77%
30 Jun, 20	26	-
31 Mar, 20	26	-

As of 30 Jun 23, 4 institutions are holding Bellicum Pharmaceuticals's shares, representing a decrease of -80.95% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 23	467,520	-66.44%
31 Mar, 23	1,392,968	-16.36%
31 Dec, 22	1,665,508	-4.59%
30 Sep, 22	1,745,689	-4.85%
30 Jun, 22	1,834,593	6.61%
31 Mar, 22	1,720,924	17.12%
31 Dec, 21	1,469,350	-4.37%
30 Sep, 21	1,536,469	-1.18%
30 Jun, 21	1,554,880	14.78%
31 Mar, 21	1,354,644	-16.95%
31 Dec, 20	1,631,066	60.00%
30 Sep, 20	1,019,385	0.73%
30 Jun, 20	1,011,951	-31.85%
31 Mar, 20	1,484,858	-

Bellicum Pharmaceuticals (BLCM) has 467.52K shares outstanding as of 30 Jun 23, down -66.44% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 23	1.52%	7.43%
31 Mar, 23	4.52%	15.48%
31 Dec, 22	5.40%	16.85%
30 Sep, 22	5.66%	15.99%
30 Jun, 22	5.95%	19.09%
31 Mar, 22	5.58%	6.38%
31 Dec, 21	9.35%	4.05%
30 Sep, 21	15.20%	6.42%
30 Jun, 21	15.38%	8.44%
31 Mar, 21	13.50%	1.68%
31 Dec, 20	28.32%	6.98%
30 Sep, 20	20.15%	5.02%
30 Jun, 20	20.03%	2.31%
31 Mar, 20	29.46%	-

As of 30 Jun 23, Bellicum Pharmaceuticals is held by 1.52% institutional shareholders, representing a 7.43% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 23	2	-66.67%
31 Mar, 23	6	-50.00%
31 Dec, 22	12	140.00%
30 Sep, 22	5	-
30 Jun, 22	5	-37.50%
31 Mar, 22	8	166.67%
31 Dec, 21	3	-50.00%
30 Sep, 21	6	-14.29%
30 Jun, 21	7	-12.50%
31 Mar, 21	8	-50.00%
31 Dec, 20	16	220.00%
30 Sep, 20	5	-50.00%
30 Jun, 20	10	-61.54%
31 Mar, 20	26	-

2 institutional shareholders have increased their position in BLCM stock as of 30 Jun 23 compared to 6 in the previous quarter (a -66.67% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 23	-	-100.00%
31 Mar, 23	4	-
31 Dec, 22	4	-
30 Sep, 22	4	-
30 Jun, 22	4	33.33%
31 Mar, 22	3	-25.00%
31 Dec, 21	4	-33.33%
30 Sep, 21	6	-25.00%
30 Jun, 21	8	166.67%
31 Mar, 21	3	-57.14%
31 Dec, 20	7	-22.22%
30 Sep, 20	9	28.57%
30 Jun, 20	7	-
31 Mar, 20	-	-

- institutional shareholders have reduced their position in BLCM stock as of 30 Jun 23 compared to 4 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 23	4	-80.95%	467,520	-66.44%	1.52%	7.43%	2	-66.67%	-	-100.00%
31 Mar, 23	21	-27.59%	1,392,968	-16.36%	4.52%	15.48%	6	-50.00%	4	-
31 Dec, 22	29	38.10%	1,665,508	-4.59%	5.40%	16.85%	12	140.00%	4	-
30 Sep, 22	21	-4.55%	1,745,689	-4.85%	5.66%	15.99%	5	-	4	-
30 Jun, 22	22	-	1,834,593	6.61%	5.95%	19.09%	5	-37.50%	4	33.33%
31 Mar, 22	22	22.22%	1,720,924	17.12%	5.58%	6.38%	8	166.67%	3	-25.00%
31 Dec, 21	18	-18.18%	1,469,350	-4.37%	9.35%	4.05%	3	-50.00%	4	-33.33%
30 Sep, 21	22	-8.33%	1,536,469	-1.18%	15.20%	6.42%	6	-14.29%	6	-25.00%
30 Jun, 21	24	9.09%	1,554,880	14.78%	15.38%	8.44%	7	-12.50%	8	166.67%
31 Mar, 21	22	-18.52%	1,354,644	-16.95%	13.50%	1.68%	8	-50.00%	3	-57.14%
31 Dec, 20	27	50.00%	1,631,066	60.00%	28.32%	6.98%	16	220.00%	7	-22.22%
30 Sep, 20	18	-30.77%	1,019,385	0.73%	20.15%	5.02%	5	-50.00%	9	28.57%
30 Jun, 20	26	-	1,011,951	-31.85%	20.03%	2.31%	10	-61.54%	7	-
31 Mar, 20	26	-	1,484,858	-	29.46%	-	26	-	-	-

Bellicum Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Nov 24, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-	X-InTheMoney	Sell	1,941,607	-	$194.16	14,217,844
Nov 24, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-	X-InTheMoney	Sell	174,742	-	$17.47	1,287,987

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Nov 24, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-	X-InTheMoney	Sell	1,941,607	-	$194.16	14,217,844
Nov 24, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-	X-InTheMoney	Buy	1,941,607	-	$194.16	2,168,818
Nov 24, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-	X-InTheMoney	Sell	174,742	-	$17.47	1,287,987
Nov 24, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-	X-InTheMoney	Buy	174,742	-	$17.47	196,654
May 05, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-		Buy	-	-	-	227,211
May 05, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-		Buy	-	-	-	21,912
May 05, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-		Buy	4,108,140	-	-	-
May 05, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-		Buy	16,159,451	-	$1.62K	-
May 05, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-		Buy	1,531,902	-	$1.53K	-
May 05, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-		Buy	1,531,902	$6.50	$9.96M	-
May 05, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-		Buy	1,615,945	$1.69	$2.73M	-
May 05, 2023	BAKER BROS. ADVISORS LP	10 percent owner	-		Buy	4,108,140	-	-	-
Jan 20, 2023	Huber Reid M	director	-	M-Exempt	Buy	80,968	-	-	146,951
Jan 05, 2023	Daly James M	director	-	M-Exempt	Buy	60,414	-	-	109,873
Jan 05, 2023	DAVIS STEPHEN	director	-	M-Exempt	Buy	74,739	-	-	136,854
Jan 05, 2023	Huber Reid M	director	-	M-Exempt	Buy	87,196	-	-	153,179
Jan 05, 2023	Stonehouse Jon P	director	-	M-Exempt	Buy	121,452	-	-	204,086
Jan 05, 2023	Klimovsky Judith V	director	-	M-Exempt	Buy	60,414	-	-	110,098
Jan 04, 2023	Stonehouse Jon P	director	-	M-Exempt	Buy	60,580	-	-	82,634
Sep 02, 2022	Klimovsky Judith V	director		M-Exempt	Buy	35,082	-	-	49,684

The last insider sell of Bellicum Pharmaceuticals's stock was made by BAKER BROS. ADVISORS LP on Nov 24 2023, selling 1,941,607 shares at - per share (valued at $194.16).

Bellicum Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	2	2	100.00%
Q2 2023	-	-	-
Q1 2023	6	-	-
Q3 2022	8	-	-
Q2 2022	5	-	-
Q1 2022	10	6	166.67%
Q4 2021	1	6	16.67%
Q3 2021	4	-	-
Q2 2021	6	-	-
Q1 2021	6	-	-
Q4 2020	2	-	-
Q2 2020	11	1	1100.00%
Q1 2020	13	12	108.33%
Q4 2019	1	2	50.00%
Q3 2019	3	1	300.00%
Q2 2019	15	5	300.00%
Q1 2019	14	26	53.85%
Q4 2018	4	-	-
Q3 2018	5	13	38.46%
Q2 2018	9	1	900.00%

2 total buy trades, and 2 total sell trades (buy/sell ratio of 1.00%) were made by Bellicum Pharmaceuticals's insiders, as of Q4 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q4 2020	-	-	-
Q2 2020	-	-	-
Q1 2020	1	-	-
Q4 2019	-	-	-
Q3 2019	3	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-
Q4 2018	1	-	-
Q3 2018	-	2	-
Q2 2018	-	1	-

As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Bellicum Pharmaceuticals's stocks.

Bellicum Pharmaceuticals Peer Ownership

Ticker	Company
CLLS	Cellectis S.A.
ADAP	Adaptimmune Therapeutics plc
CALA	Calithera Biosciences, Inc.
AFMD	Affimed N.V.
ATRA	Atara Biotherapeutics, Inc.

BLCM Ownership FAQ

Who Owns Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals is owned by institutional shareholders (1.52%), insiders (0.99%), and public (97.50%). The largest institutional shareholder of Bellicum Pharmaceuticals is IKARIAN CAPITAL, LLC (1.45% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.03% of total shares).

Who are the major institutional shareholders of Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals's major institutional shareholders are IKARIAN CAPITAL, LLC, LONG FOCUS CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, BLACKROCK INC., and GEODE CAPITAL MANAGEMENT, LLC. The top five shareholders own together 3.81% of the company's share outstanding.

How many Bellicum Pharmaceuticals shareholders are there?

As of Jun 2023, there are 4 institutional shareholders of Bellicum Pharmaceuticals.

What percentage of Bellicum Pharmaceuticals is owned by IKARIAN CAPITAL, LLC?

IKARIAN CAPITAL, LLC owns 448.1K shares of Bellicum Pharmaceuticals, representing 1.45% of the company's total shares outstanding, valued at $147.87M (as of Mar 2023).

What percentage of Bellicum Pharmaceuticals is owned by LONG FOCUS CAPITAL MANAGEMENT, LLC?

As of Mar 2023, LONG FOCUS CAPITAL MANAGEMENT, LLC holds 327.69K shares of Bellicum Pharmaceuticals (BLCM), compromising 1.06% of the company, valued at $108.14M.

What percentage of Bellicum Pharmaceuticals is owned by BAKER BROS. ADVISORS LP?

BAKER BROS. ADVISORS LP is the third largest holder of Bellicum Pharmaceuticals. The company owns 249.12K of the company's shares outstanding (worth $82.21M).